Henrijette Richter discusses R&D in plenary at WuXi Global Forum

Related Deal lead

Related Strategy

Henrijette Richter, managing partner at Sofinnova Partners, participated in the opening plenary panel discussion at the WuXi Global Forum 2022 on January 10. Marking the 10th anniversary of the event, the panel, led by Jorge Conde, general partner at Andreessen Horowitz, took a look back at 10 years of breakthroughs that are changing the game in R&D productivity before turning their focus on the future. Henrijette joined David Berry, founder and CEO of Valo Health; Diego Miralles, CEO of Laronde, and Roger Perlmutter, chairman and CEO of Eikon Therapeutics.
View the replay here.

Henrijette Richter discusses R&D in plenary at WuXi Global Forum

Henrijette Richter discusses R&D in plenary at WuXi Global Forum

ProQR Announces Appointment of Chris Hart as Chief Data and AI Officer and Thomas Wolf to join the Board of Directors as Strategic AI Advisor

HighLife Raises $90+Million to start its US Pivotal Study and accelerate Commercial Expansion in Europe

Before the breakthrough: Sofinnova's decade-long bet on HighLife

GlycoEra Appoints Andrea Matthews as Chief Business Officer to Support Next Phase of Company Growth

Actithera strengthens leadership team and Board as company advances towards clinical development

Bionyra Pharma announces first healthy volunteers dosed in Phase 1 study of BYN-001, a long-acting IL-25 antibody for atopic dermatitis